YMTracker DRIPCalc v2 Launch sale

NEW Our free Dividend Tracker is live — see what your stocks pay you

Add your stocks and see every dividend they pay you — dates, amounts, and reinvested shares.

Kamada Ltd. KMDA | NASDAQ

$7.88 -$0.20 | -2.48%

TREND SIGNAL: Signal available — unlock to view

Signal available — unlock to view

|2026-10-06

Add to favoritesFavorite

Company Overview:

Market Cap: $466.30M

Trailing PE: 20.8x

FWD PE *: 15.8x

Payout Ratio (TTM): 65.9%

52-Week Range: $6.55 - $9.35

* Forward PE is based on street estimates.

10 Year KMDA Performance Metrics:

Total Return (with DRIP): 52.1% (4.28% CAGR)

Total Return (no DRIP): 51.0% (4.21% CAGR)

Share Price: 40.0% (3.42% CAGR)

Yield on Cost (with DRIP): 13.12%

Total Invested: $10,000

Total Value (with DRIP): $15,206

Total Return $ (with DRIP): $5,206

Dividend Increase: 0.0% (0.00% CAGR)

Dividend Yield (FWD): 8.63% ($0.68)

KMDA 10-yr Total Return ($10K invested)

1M 3M 6M YTD 1Y 3Y 5Y 10Y

KMDA Share Price

1M 3M 6M YTD 1Y 3Y 5Y 10Y All

KMDA Price CAGR:1Y: 14.53%2Y: 22.51%5Y: 8.50%10Y: 3.42%

KMDA Dividend Charts

KMDA - Dividends

KMDA Dividend CAGR:1Y: 28.82%2Y: 28.82%5Y: 28.82%10Y: 28.82%

KMDA - Dividend Payout Ratio

KMDA Dividend Payout Ratio CAGR:1Y: -0.43%2Y: 0.00%5Y: 0.00%10Y: 0.00%

KMDA - Dividend to Free Cash Flow Ratio

KMDA Dividend to FCF Ratio CAGR:1Y: -52.94%2Y: 0.00%5Y: 0.00%10Y: 0.00%

Unlock All Reports & Research Dividend Stocks like a BOSS!

Get 3 Months Free with Annual Plan

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

Combined 55% Lifetime Discount

Most Popular

PREMIUM

$288 ($24/mo) $172.80/yr ($14.40/mo)

7-day free trial

Everything in Pro
YieldMax PNL Tracker
YieldMax NAV Erosion Alerts
YM ETFs Trend Signals
9/21 EMA Trend Signals
Stocks Dashboard

Try it free for 7 days

Combined 55% Lifetime Discount

ULTRA

$576 ($48/mo) $345.60/yr ($28.80/mo)

7-day free trial

Everything in Premium
15min & 1hr Intraday Signals
Group & weekly ETF estimates
YouTuber Mode
Trades summary + CSV export
Priority data & support

Try it free for 7 days

Combined 55% Lifetime Discount

KMDA Financials: Earnings, Revenue, Cash Flow, Ebitda, Cash/Debt, Shares Float, etc:

KMDA - Revenue

KMDA Revenue CAGR:1Y: 22.72%2Y: 14.52%5Y: 17.77%10Y: 11.16%

KMDA - Earnings Per Share (EPS)

KMDA EPS CAGR:1Y: 23.08%2Y: 41.42%5Y: 51.57%10Y: 0.00%

KMDA - Net Income

🔓 See the full chart40% off right now · 7-day free trial

KMDA Net Income CAGR:1Y: 25.57%2Y: 44.66%5Y: 58.12%10Y: 0.00%

KMDA - EBITDA

🔓 See the full chart40% off right now · 7-day free trial

KMDA EBITDA CAGR:1Y: 38.28%2Y: 30.55%5Y: 42.62%10Y: 35.59%

KMDA - Free Cash Flow

🔓 See the full chart40% off right now · 7-day free trial

KMDA Free Cash Flow CAGR:1Y: 165.71%2Y: 22.15%5Y: 0.00%10Y: 0.00%

KMDA - Free Cash Flow / Share

🔓 See the full chart40% off right now · 7-day free trial

KMDA Free Cash Flow / Share CAGR:1Y: 160.43%2Y: 19.42%5Y: 0.00%10Y: 0.00%

KMDA - Operating Income

🔓 See the full chart40% off right now · 7-day free trial

KMDA Operating Income CAGR:1Y: 34.49%2Y: 29.85%5Y: 55.50%10Y: 0.00%

KMDA - Gross Profit

🔓 See the full chart40% off right now · 7-day free trial

KMDA Gross Profit CAGR:1Y: 18.69%2Y: 9.65%5Y: 19.89%10Y: 14.84%

KMDA - Shares Outstanding

🔓 See the full chart40% off right now · 7-day free trial

KMDA Shares Outstanding CAGR:1Y: 2.03%2Y: 2.29%5Y: 4.32%10Y: 3.86%

KMDA - Share Buybacks

🔓 See the full chart40% off right now · 7-day free trial

KMDA Share Buybacks CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

KMDA - Stock-Based Comp

🔓 See the full chart40% off right now · 7-day free trial

KMDA Stock-Based Comp CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

KMDA - Expenses

🔓 See the full chart40% off right now · 7-day free trial

KMDA Expenses CAGR:1Y: 4.62%2Y: -15.71%5Y: 9.61%10Y: 14.52%

KMDA - Revenue vs Net Income

🔓 See the full chart40% off right now · 7-day free trial

KMDA - EPS vs FCF / Share

🔓 See the full chart40% off right now · 7-day free trial

KMDA - EPS vs PE Ratio

🔓 See the full chart40% off right now · 7-day free trial

KMDA - FCF vs FCF / Share

🔓 See the full chart40% off right now · 7-day free trial

KMDA - FCF vs Stock Based Comp

🔓 See the full chart40% off right now · 7-day free trial

KMDA - Cash & Debt

🔓 See the full chart40% off right now · 7-day free trial

KMDA - Revenue by Region

🔓 See the full chart40% off right now · 7-day free trial

KMDA Revenue CAGR:1Y: 22.72%2Y: 14.52%5Y: 17.77%10Y: 11.16%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

KMDA - REVENUE: Actual + Estimates

🔓 See the full chart40% off right now · 7-day free trial

KMDA Actual Revenue CAGR:1Y: 22.72%2Y: 14.52%5Y: 17.77%10Y: 11.16%

KMDA - EPS: Actual + Estimates

🔓 See the full chart40% off right now · 7-day free trial

KMDA Actual EPS CAGR:1Y: 23.08%2Y: 41.42%5Y: 51.57%10Y: 0.00%

KMDA - NET INCOME: Actual + Estimates

🔓 See the full chart40% off right now · 7-day free trial

KMDA Actual Net Income CAGR:1Y: 25.57%2Y: 44.66%5Y: 58.12%10Y: 0.00%

KMDA - EBITDA: Actual + Estimates

🔓 See the full chart40% off right now · 7-day free trial

KMDA Actual EBITDA CAGR:1Y: 38.28%2Y: 30.55%5Y: 42.62%10Y: 35.59%

Ratios, Profit Margins & Return on Capital:

KMDA - Net Profit Margin

🔓 See the full chart40% off right now · 7-day free trial

KMDA Net Profit Margin CAGR:1Y: 2.31%2Y: 26.30%5Y: 34.22%10Y: 0.00%

KMDA - Gross Profit Margin

🔓 See the full chart40% off right now · 7-day free trial

KMDA Gross Profit Margin CAGR:1Y: -3.29%2Y: -4.25%5Y: 1.79%10Y: 3.32%

KMDA - Price to Earnings

🔓 See the full chart40% off right now · 7-day free trial

KMDA Price to Earnings CAGR:1Y: -23.05%2Y: -12.83%5Y: -30.25%10Y: 0.00%

KMDA - Price To Sales Ratio

🔓 See the full chart40% off right now · 7-day free trial

KMDA Price To Sales Ratio CAGR:1Y: -21.26%2Y: 10.11%5Y: -6.36%10Y: 0.14%

KMDA - Return on Capital Employed

🔓 See the full chart40% off right now · 7-day free trial

KMDA Return on Capital Employed CAGR:1Y: 29.82%2Y: 24.93%5Y: 38.94%10Y: 0.00%

KMDA - Return on Invested Capital

🔓 See the full chart40% off right now · 7-day free trial

KMDA Return on Invested Capital CAGR:1Y: 17.89%2Y: 20.05%5Y: 39.71%10Y: 0.00%

KMDA Dividends Info:

Annual Dividend: $0.68

Forward Yield: 8.63%

Ex-Dividend Date: 2026-08-27

Lifetime Dividends / Share: $0.63

KMDA Dividend History: Dates, Payments & Yield list

Below is a schedule of all KMDA dividend payments, ex-dates, share price on the day of the payment as well as the annualized yield & forward yield

Ex-Date	Payment Date	Amount	Yield	Forward Yield	Price on Ex-Date
08/27/2026	09/17/2026	$0.170	8.23%	7.84%	$8.67
03/23/2026	04/07/2026	$0.250	12.2%	12.12%	$8.25
03/17/2025	04/07/2025	$0.200	11.75%	13.69%	$5.84
06/13/2013	06/20/2013	$0.006	0.22%	0.22%	$11.01

Projected Future Returns & Dividends for KMDA

Based on past 10-year performance, here are KMDA growth metrics:

Share price CAGR of +3.42%
Dividend CAGR of +39.71%

Using KMDA CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

	KMDA (DRIP)	KMDA - No DRIP
Current Price	$7.88	$7.88
Start Shares	1,269.04	1,269.04
Start Value	$10,000	$10,000

After 10 years:
Final Share Count	2,980.30	1,269.04
Dividends Payment	$0.17	$0.17
Annual Dividends	$2,027	$863
Yield on cost	20.27%	8.63%
Share Price	$7.88	$7.88
Total Dividends	$13,485	$8,629
Final Value	$23,485	$18,629

Estimated Future Value + Dividends - KMDA

NOTE: Above numbers are our estimate based on KMDA's Dividend and Price CAGR over past 10 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Get 3 Months Free with Annual Plan

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

Combined 55% Lifetime Discount

Most Popular

PREMIUM

$288 ($24/mo) $172.80/yr ($14.40/mo)

7-day free trial

Everything in Pro
YieldMax PNL Tracker
YieldMax NAV Erosion Alerts
YM ETFs Trend Signals
9/21 EMA Trend Signals
Stocks Dashboard

Try it free for 7 days

Combined 55% Lifetime Discount

ULTRA

$576 ($48/mo) $345.60/yr ($28.80/mo)

7-day free trial

Everything in Premium
15min & 1hr Intraday Signals
Group & weekly ETF estimates
YouTuber Mode
Trades summary + CSV export
Priority data & support

Try it free for 7 days

Combined 55% Lifetime Discount

Company Info

Kamada Ltd. (KMDA) had its IPO on 2013-05-31, and is traded on NASDAQ stock exchange.

Kamada Ltd. is a biopharmaceutical firm focused on developing, manufacturing, and distributing protein therapeutics derived from human plasma. The company operates through two core business areas: its proprietary product segment and its distribution division. Its own manufactured portfolio includes KAMRAB/KEDRAB for rabies prevention, CYTOGAM to prevent cytomegalovirus disease in transplant recipients, WINRHO SDF for immune thrombocytopenic purpura and Rhesus (Rh) isoimmunization, HEPAGAM B for hepatitis B recurrence prevention following liver transplants and for post-exposure prophylaxis, VARIZIG for post-exposure chickenpox prophylaxis, and GLASSIA for intravenous alpha-1 antitrypsin deficiency (AATD). Kamada also produces KamRho (D) for the prophylaxis of hemolytic disease of newborns and immune thrombocytopenic purpura, along with a specific antiserum for Vipera palaestinae and Echis coloratus snake bites. Additionally, the company distributes a wide array of third-party pharmaceutical products, encompassing treatments like BRAMITOB for chronic pulmonary infections, FOSTER for asthma, PROVOCHOLINE for diagnosing bronchial airway hyperactivity, and specialized therapies such as IVIG for immunodeficiency, VARITECT for chickenpox and zoster herpes, and various factors for hemophilia A and B, among numerous others for conditions like hepatitis B, cytomegalovirus, angioedema, Japanese encephalitis, and prostate cancer. Kamada markets its offerings in the United States through strategic partners and internationally via a network of distributors. The company maintains significant collaborations with Takeda Pharmaceuticals Company Limited, PARI GmbH, and Kedrion Biopharma. Established in 1990, Kamada Ltd. is headquartered in Rehovot, Israel.

KMDA website: https://www.kamada.com

Get Full Access to All Reports with DRIPCalc PRO

Get 3 Months Free with Annual Plan

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

Combined 55% Lifetime Discount

Most Popular

PREMIUM

$288 ($24/mo) $172.80/yr ($14.40/mo)

7-day free trial

Everything in Pro
YieldMax PNL Tracker
YieldMax NAV Erosion Alerts
YM ETFs Trend Signals
9/21 EMA Trend Signals
Stocks Dashboard

Try it free for 7 days

Combined 55% Lifetime Discount

ULTRA

$576 ($48/mo) $345.60/yr ($28.80/mo)

7-day free trial

Everything in Premium
15min & 1hr Intraday Signals
Group & weekly ETF estimates
YouTuber Mode
Trades summary + CSV export
Priority data & support

Try it free for 7 days

Combined 55% Lifetime Discount

Loading signals…

DCF Model — KMDA

Value from:

EPS (TTM)icompany profit per share over the last 12 months

EPS Growth %ihow fast profit per share grows each of the next 5 years — prefilled with what analysts expect

EPS growth after year 5 (forever)ithe slower pace once the fast 5 years are over — only drives years 6-10 of the price path below

Exit multiple (PE in 5 yrs)iwhat buyers pay per $1 of profit in 2031 — prefilled with today’s forward PE

Desired return %/yrithe yearly return you want from buying today — the S&P has done ~14%/yr, ask for more from a single stock

FCF growth %/yr (next 5 yrs)ihow fast free cash flow grows while the company is still expanding fast

Years of fast FCF growthihow many years the fast growth lasts before the business settles down

FCF growth after year 5 (forever)ithe slow, steady pace once the company is mature — usually 2-3%, near inflation. Must stay below your target return

Risk-free rate %iwhat a 10-yr US treasury pays with zero risk — the floor any risky stock must beat

Your target return %/yrithe yearly return you want for taking this risk — rule of thumb: risk-free rate + extra for risk

FCF base ($M, TTM)ilast 12 months of free cash flow, added up from reported quarters

Include dividends in returnidividends hand you part of the return in cash, so the share price needs to climb less

Pay up to today

—

vs current price $7.88

—

Cash flow & implied price by year

FCF is negative or missing for this company (common for banks) — the model discounts EPS instead.

EPS is negative or missing for this company — Simple mode uses free cash flow per share instead.

Free cash flow today

—

grows for the next years

Then mature

—

every future dollar counted back to today

Pile of today-dollars

—

÷ shares

Implied price path

Year	FCF	Implied price

Sensitivity — fair value: growth ↓ × target return →

× Free Portfolio Tracker

Own KMDA? See every dividend it's paid you

Add your KMDA shares to a free account and every payment you've received is listed — dated, in dollars — with reinvested shares counted and monthly totals. Room for 4 more stocks.

✓Every KMDA dividend you've received, dated, with the amount
✓Reinvested (DRIP) shares counted for you
✓Monthly totals across up to 5 stocks

Add KMDA free →

Free plan · up to 5 holdings